Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study page now displays that recruitment has ended, and new sections for How to Read a Study Record, Common Questions, and How to Join a Study have been added. Additionally, the label formatting for Intervention/Treatment was adjusted and the Revision tag updated to v3.6.0.SummaryDifference0.5%

- Check20 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, indicating a new version of the page layout or content. This is a system-level update and does not reflect changes to the study data or visible content, but may include minor fixes or enhancements to the page.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new release or update to the page’s documentation. This change does not modify the study content, eligibility criteria, or results.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, indicating a tooling or platform update rather than a change to the underlying study information.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision badge updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.